Dr. Phu Ngoc Tran, MD

Dr. Tran practices at Hematology-Oncology Associates of the Treasure Coast in Port Saint Lucie, Florida.

Dr. Tran's NPI, 1891089587, was assigned on May 31, 2011. Dr. Tran graduated from Creighton University School of Medicine - Omaha in 2011. Dr. Tran's Ohio license number on file is 131186.

Dr. Tran's primary practice is Hematology-Oncology Associates of the Treasure Coast, at 1871 SE Tiffany Ave, Port Saint Lucie, FL 34952 in Saint Lucie County. The practice phone is (772) 335-5666.

Dr. Tran's primary practice is Hematology-Oncology Associates of the Treasure Coast in Port Saint Lucie, Florida. Dr. Tran is also affiliated with HCA Florida St. Lucie Hospital. The medical group on file is Hematology Oncology Associates of the Treasure Coast. Dmand AI also links Dr. Tran to 2 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Tran practices, 4 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Tran's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Tran is board certified in hematology by the American Board of Internal Medicine. Dmand AI has Dr. Tran's licenses on file in 5 states: Ohio, Texas, Florida, California and Pennsylvania.

Dmand AI lists breast cancer, chronic anemia, chronic embolism thrombosis, chronic leukemia, colorectal cancer, deep vein thrombosis (DVT), immune deficiency disease and lung cancer among the conditions Dr. Tran treats.

CMS data shows 173,267 Medicare services from Dr. Tran across 71 procedure codes in 2024, for 1,176 Medicare patients. Medicare paid $1,595,274 for them.

CMS counts 1,176 Medicare patients who saw Dr. Tran in 2024. The largest group is 75 to 84, with 482 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 11% are also on Medicaid. Their average risk score is 2.22, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Tran's median patient age at 72, with 55% women.

In 2024, Dr. Tran wrote 2,752 Medicare Part D claims for 470 patients. 70% of them were for generic drugs. CMS names the drug for 2,296 of them, across 69 drugs with 11 or more claims each, at $5,884,000 in total drug cost. In 2023, CMS named 1,451 claims across 52 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Dr. Tran for performance year 2024, reported as part of a group. Dr. Tran accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 15 papers to Dr. Tran, published from 2012 to 2019. 2017 was the busiest year, with 6. The most frequent topics are Anticoagulants, Antineoplastic Agents and Antineoplastic Combined Chemotherapy Protocols. Dr. Tran's most frequent co-authors are Minh-Ha Tran, DO, Susan M. O'Brien, MD and Joseph Chao, MD.

CMS Open Payments shows 830 general payments to Dr. Tran from 56 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 43% of the total. AstraZeneca Pharmaceuticals LP paid the most, $12,216.

Dr. Tran graduated from Creighton University School of Medicine - Omaha in 2011.

Dr. Tran is in network with 18 carriers, including Aetna, Excellus BlueCross BlueShield and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.